ARCHIVES

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

Phase II Study Of Pfizer Drug Meets Primary Endpoint

April 24, 2009

Gigliotti Appointed Chief of Education Branch In DRCCA

January 21, 1983

In Brief: USC Study Finds Sedentary Occupations Increase Colon Cancer Risk for Men Over More Active Jobs

November 30, 1984

Herberman: Progress Made To Stabilize NSABP

September 9, 1994

NCI Awards $10 Million To States for Cervix Screening

September 27, 1974

DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts

November 9, 1979